Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2006
10/26/2006DE102005020105A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for the preparation of medicament to treat e.g. cancer, autoimmune disease, cardiovascular disease stenosis and infection disease
10/26/2006DE102005020104A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for the preparation of medicament to treat e.g. cancer, autoimmune disease, cardiovascular disease stenosis and infection disease
10/26/2006DE102005019094A1 New aza-heterocyclic compounds are tyrosine kinase inhibitor useful to prevent and/or treat cancer, tumor growth, tumor angiogenesis, arteriosclerosis, diabetic retinopathy and inflammation diseases
10/26/2006CA2605059A1 Oxindole compounds and their uses as therapeutic agents
10/26/2006CA2604912A1 Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci
10/26/2006CA2604295A1 Roflumilast for the treatment of pulmonary hypertension
10/25/2006EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/25/2006EP1714970A1 Use of inhibitors of RNAse A-family enzymes for stabilizing oligonucleotides having RNA interfering activity
10/25/2006EP1714963A1 Process for the Preparation of Valsartan and its Intermediates
10/25/2006EP1714961A1 Indazole compound and pharmaceutical use thereof
10/25/2006EP1714661A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
10/25/2006EP1714659A1 A biological active blood serum for the treatment of stroke
10/25/2006EP1714654A1 Drug for inhibiting vascular intimal hyperplasia
10/25/2006EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm
10/25/2006EP1714651A1 Use of angiotensin II receptor antagonists for treating acute myocardial infarction
10/25/2006EP1714648A1 Combination drug
10/25/2006EP1713797A1 1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE DERIVATIVES HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY
10/25/2006EP1713771A1 New crystalline form of perindopril
10/25/2006EP1713541A1 Use of alkaline phosphatase for the detoxification of lps
10/25/2006EP1713480A2 The use of quaternary pyridinium salts as vasoprotective agents
10/25/2006EP1713469A1 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent
10/25/2006EP1713467A1 Compositions and methods of use of a-type procyanidins
10/25/2006EP1713462A1 A method of modulating pro-inflammatory and inflammatory activity mediated by c-reactive protein
10/25/2006EP1713452A2 Sustained release pharmaceutical composition of indapamide
10/25/2006EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/25/2006EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
10/25/2006EP1490030B1 Nanoparticulate compositions of angiogenesis inhibitors
10/25/2006EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
10/25/2006EP1392689B1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists
10/25/2006EP1331938B1 Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
10/25/2006EP1313476B1 Sgk3 used as diagnostic and therapeutic target
10/25/2006EP1153302B1 Diagnostics and therapeutics for macular degeneration
10/25/2006EP1097167B1 Neurotrophic growth factor
10/25/2006EP1079811B1 Biodegradable sustained-release alginate gels
10/25/2006EP0828849B1 High-affinity oligonucleotide ligands to pdgf
10/25/2006EP0827408B1 Method of administration of igf-i
10/25/2006CN1852979A Modulation of eIF4E expression
10/25/2006CN1852749A Use of dapsone as a neuroprotector in cerebral infarction
10/25/2006CN1852748A Azepine derivatives as pharmaceutical agents
10/25/2006CN1852744A Endoluminal prosthesis comprising a therapeutic agent
10/25/2006CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
10/25/2006CN1852726A Oral compositions for the treatment of cellulite
10/25/2006CN1852710A Pyrazolines as PAR-1 antagonists for treatment of cardiovascular diseases
10/25/2006CN1852709A Macrophage activation inhibitor
10/25/2006CN1850847A Method for preparing periplogenin
10/25/2006CN1850838A Scutellarin raw material drug preparing method
10/25/2006CN1850836A Celosia argentea suponin compound and its pharmaceutical use
10/25/2006CN1850820A Coumarin derivatives, and their preparing method and use as alpha, receptor agonist
10/25/2006CN1850801A Method for preparing amlodipine benzenesulfonate
10/25/2006CN1850764A 6,7-dehydroxyleanone in salvia farinacea root with platelet aggregation inhibition
10/25/2006CN1850261A Medicine composition for treating apoplexy and apoplexy involving both collateral and meridian and preparing method
10/25/2006CN1850254A Chinese medicine preparation for treating deficiency of qi and blood and preparing method
10/25/2006CN1850212A Valerianoil liquid hard capsule, and its preparing method
10/25/2006CN1850207A Fructus-sophorae Radix et Rhizoma sanguisorbae preparation and new preparing method
10/25/2006CN1850192A Medicine composition for treating cerebral embolism sequela and rheumatoid arthritis and preparing method
10/25/2006CN1850186A Medicine for treating cerebral hemorrhage and preparing method
10/25/2006CN1850185A Yixinshu Injecta for retaliation of Qi and pulse and promotion of blood circulation and removing of blood stasis, and preparing method therefor
10/25/2006CN1850160A Qidantongmai Tablet, and its preparing process
10/25/2006CN1850153A Method for preparing Radix puerariae and cenlian decoction
10/25/2006CN1850139A Preparing method for oral instant-dissolving tablet for calming brain
10/25/2006CN1850137A Method for preparing Radix-Acanthopanacis-leaf extract for treating cardiovascular and cerebrovascalar diseases
10/25/2006CN1850131A Medicine composition for treating cardiovascular and cerebrovascular diseases
10/25/2006CN1850129A Medicine preparation for preventing and treating heart brain and kidney blood vessel diseases
10/25/2006CN1850128A Pine pollen composition with beauty nourish function to face, intensifying immunity of body
10/25/2006CN1850093A Stibene-glucoside oral liquid and its production method
10/25/2006CN1850081A Use of 5-(3-aminobenzene)methyl nicotinate and its ahalogue as PI3K enzyme inhibitor
10/25/2006CN1850073A Medicinal composition containing ampicillin and its preparing method
10/25/2006CN1850069A Method for preparing Tengchasu dispersibletablet and its use
10/25/2006CN1850068A Medicinal composition for treating cardio-cerebral-vascular disease and its preparing method
10/25/2006CN1850057A Method for preparing insoluble drug single-tablet-core single-chamber osmotic pump sustained-release preparations and its product
10/25/2006CN1850055A Flunarizine hydrochloride lyophilized agent for injection and its preparing method
10/25/2006CN1281743C Preparation method of earthworm kinase dry powder
10/25/2006CN1281608C New azo-indolyl derivatives
10/25/2006CN1281604C Substituted pyrazole compounds
10/25/2006CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006CN1281597C New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias
10/25/2006CN1281590C Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity
10/25/2006CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006CN1281585C Cyclic diamine compounds having fused-ring groups
10/25/2006CN1281278C Gene-carrying micro-bublle of target transfergene, its preparation method and use
10/25/2006CN1281268C Chinese medicinal composition for supplementing Qi, nourishing heart and calming mind and its preparation and identification method
10/25/2006CN1281261C Capsule for treating hypertension and coronary disease and its preparing method
10/25/2006CN1281240C Medicinal composition for preventing and treating cardiovascular heart disease and its preparation
10/25/2006CN1281231C External use medicinal composition for softening and dredging pyramis arteriosclerosis and its preparation method
10/25/2006CN1281227C Bunao Yishen Runchang Capsule for replenishing brain and kidney and moistening intestines
10/25/2006CN1281223C Myocarditis treating medicine and its preparing process
10/25/2006CN1281219C Medicine for treating piles and its preparation method
10/25/2006CN1281217C Use of activated carbon in oral medicinal preparation for hyperthyroidism
10/25/2006CN1281215C The second purpose of Siberian solomonseal rhizome polysaccharide
10/25/2006CN1281214C Process for preparing ginkgo leaf extract powder injection
10/25/2006CN1281213C Process method for preparing sodium chloride injection of ginkgo leaf extract
10/25/2006CN1281212C General saponin of stem and leaf of American ginseng in Application of preparing medication for treating mycoarditis
10/25/2006CN1281206C Orally disintegrating tablet of 'Xinxuekang' and manufacture method of the same
10/24/2006US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006US7126008 Carvedilol
10/24/2006US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006US7125906 Indole derivatives having anti-angiogenetic activity